Page 1,574«..1020..1,5731,5741,5751,576..1,5801,590..»

Cyberterrorism and Biotechnology – Foreign Affairs (subscription)

Posted: June 2, 2017 at 6:42 am

For years, the international community has grappled with the threat of chemical, biological, radiological, and nuclear terrorism. And although al Qaeda and the Islamic State (ISIS) have demonstrated interest in and some capability to develop and use such weapons, there have been no successful mass casualty terrorist attacks involving them. Attempted attacks involving radiological dispersal devices or chemical and biological means have either failed or had a very limited impact. Experts such as John Parachini, Jeffrey Bale and Gary Ackerman, Adam Dolnik, and Rajesh Basrur and Mallika Joseph argue that the reason is terrorists inability to weaponize chemical, biological, radiological, or nuclear material. Others, including Brian Michael Jenkins, believe that the lack of mass causality attacks also has to do with self-restraint: perpetrators might not be able to control the consequences of such an attack. It could end up harming the members of the communities that the terrorists are purportedly fighting for and could therefore be counterproductive.

The recent WannaCry ransomware attack, however, could force the expert community to rethink such positions. Although available information suggests that North Korean hackers were behind these attacks, in which hackers took control of about 300,000 computers in over 150 countries and held the victims hostage in exchange for a payment of $300 in bitcoin, there is reason to believe that terrorist groups such as al Qaeda and ISIS could copy the tactic. In doing so, they would cause as much damage (loss of data and equipment) and chaos (in hospitals and other public utilities) as possible, comparable to the chaos and panic that could be caused by a chemical or biological attack.

Terrorists could use cyber capabilities to target any sector. But the most vulnerable industries are those with high proportions of old infrastructure onto which new technology has been grafted. According to a report from the U.S. Bureau of Economic Analysis, in 2015, the average age of all fixed assets in the United States stood at 22.8 years, with hospitals and utilities some of the worst culprits.

See more here:
Cyberterrorism and Biotechnology - Foreign Affairs (subscription)

Posted in Biotechnology | Comments Off on Cyberterrorism and Biotechnology – Foreign Affairs (subscription)

Global Biotechnology Separation Systems Market 2017-2022: – People Exclusive

Posted: June 2, 2017 at 6:42 am

Global Biotechnology Separation Systems market Report offers decisive insights into the overall Biotechnology Separation Systems industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Biotechnology Separation Systems industry segments based on the type of applications, type of product Components and services, and different geographical regions.

At First, the research study provides exquisite knowledge of the global Biotechnology Separation Systems market structure, valuates and outlines its variable aspects & applications.

Further, Biotechnology Separation Systems market report along with computable information, qualitative information sets and evaluation tools are provided in this study for improved Biotechnology Separation Systems analysis of the overall market scenario and future prospects. Information such as Biotechnology Separation Systems industry predilection insights and drivers, challenges and fortuity assists the readers for understanding the current trends in the global Biotechnology Separation Systems market. Tools such as market positioning of Biotechnology Separation Systems key players and tempting investment scheme provide the readers with perception on the competitive scenario of the worldwide Biotechnology Separation Systems market. This Biotechnology Separation Systems report concludes with company profiles section that points out major data about the vital players involved in global Biotechnology Separation Systems industry.

Do Inquiry Before Accessing 2017-2022 Global Biotechnology Separation Systems Market Report at https://market.biz/report/global-biotechnology-separation-systems-market-gir/28805/#inquiry

In order to help key decision makers, the Biotechnology Separation Systems report also includes competitive depicting of the leading players in global Biotechnology Separation Systems market, tempting investment scheme market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Danaher Thermo Fisher Scientific BD Merck GE Healthcare Agilent Sysmex Alfa Wassermann Shimadzu Sartorius Stedim Biotech Illumina Waters Novasep 3M Purification Affymetrix Bio-Rad Laboratories Alfa Laval PerkinElmer Repligen Hitachi Koki

The industry research is disperse over the world which includes Biotechnology Separation Systems market in North America (USA, Canada and Mexico), Biotechnology Separation Systems market in Asia-Pacific (China, Japan, Korea, India and Southeast Asia), Biotechnology Separation Systems market in Europe (Germany, France, UK, Russia and Italy), Biotechnology Separation Systems market in South America (Brazil, Argentina, Columbia etc.), Biotechnology Separation Systems market in Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) and Other parts of the Globe. Due to increasing job opportunities in Asia-Pacific countries, China and India will show a tremendous development in the global Biotechnology Separation Systems market. Use of advanced technology is holding the largest global Biotechnology Separation Systems market share in North America. Adoption of Biotechnology Separation Systems in the distinct fields in Europe will help to increase the expansion of Biotechnology Separation Systems market globally.

Commercial Scientific research

Membrane Filtration Chromatography Centrifuge Electrophoresis Flow Cytometry Others

Gain Full Access of Global Biotechnology Separation Systems Market Report with complete TOC at https://market.biz/report/global-biotechnology-separation-systems-market-gir/28805/

At last, Brief Description of Each Chapter is provided

Reports Consists 15 Chapters in it which thoroughly exhibit the global Biotechnology Separation Systems market 2017-2022.

Chapter 1, to features Biotechnology Separation Systems Introduction, product purview, market synopsis, market opportunities of Biotechnology Separation Systems, market peril, market motive;

Chapter 2, examines the top manufacturers in Biotechnology Separation Systems, with sales, revenue, and price of Biotechnology Separation Systems, in 2016 and 2017;

Chapter 3, exhibits the competitive situation among the Biotechnology Separation Systems top manufacturing players, with sales, revenue, and market share in 2016 and 2017;

Chapter 4, explores regionwise analysis of global Biotechnology Separation Systems market, with sales, revenue and market share, for each Biotechnology Separation Systems region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, scrutinizes the Biotechnology Separation Systems key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, displays the market based on Biotechnology Separation Systems type and application, with sales market share and Biotechnology Separation Systems growth rate by type, application, from 2012 to 2017;

Chapter 12, deals with Biotechnology Separation Systems market prognosis, by regions, type, and application, with Biotechnology Separation Systems sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, explores Biotechnology Separation Systems industry sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source for Biotechnology Separation Systems.

The Industry study on global Biotechnology Separation Systems market encompasses full in-depth analysis of the parent market and provides important changes in Biotechnology Separation Systems dynamics. It also includes Former, on-going, and projected global Biotechnology Separation Systems market analysis in terms of volume and value.

The industry report on Biotechnology Separation Systemsserves comprehensive information about Segmentation details of the market in Biotechnology Separation Systems, Key strategies of major players, Market share analysis, and Biotechnology Separation Systems Emerging segments and regional markets.

Along with the Assessment of niche industry developments, global Biotechnology Separation Systems market report covers Testimonials to companies in order to fortify their foothold in the market.

Thus, the research study provides a comprehensive view of the global Biotechnology Separation Systems market, offering market dimensions and evaluations for the period from 2017 to 2022, keeping in mind the aforementioned factors.

Sumana Oza has been into market research industry for last 5 years. She has a keen interest and deep knowledge of research industry. She worked as an Research Analyst in GlobeMertix. Her goals in life are simple - to stay happy, healthy and to keep writing as long as she possibly can.

Read more from the original source:
Global Biotechnology Separation Systems Market 2017-2022: - People Exclusive

Posted in Biotechnology | Comments Off on Global Biotechnology Separation Systems Market 2017-2022: – People Exclusive

One gene closer to regenerative therapy for muscular disorders – Medical Xpress

Posted: June 2, 2017 at 6:42 am

June 1, 2017 This microscopic image of fibroblast cells shows the induction of cell fusion by a newly described gene and its protein, called myomerger. Multi-nucleus cells expressing genes needed to form skeletal muscle can be seen in flower-like clumps forming as cells fuse together. Reporting results in Nature Communications, the researchers seek ways to develop regenerative therapies for muscle disorders by getting stem cells to fuse and form functioning skeletal muscle tissues. Credit: Cincinnati Children's

A detour on the road to regenerative medicine for people with muscular disorders is figuring out how to coax muscle stem cells to fuse together and form functioning skeletal muscle tissues. A study published June 1 by Nature Communications reports scientists identify a new gene essential to this process, shedding new light on possible new therapeutic strategies.

Led by researchers at the Cincinnati Children's Hospital Medical Center Heart Institute, the study demonstrates the gene Gm7325 and its protein - which the scientists named "myomerger" - prompt muscle stem cells to fuse and develop skeletal muscles the body needs to move and survive. They also show that myomerger works with another gene, Tmem8c, and its associated protein "myomaker" to fuse cells that normally would not.

In laboratory tests on embryonic mice engineered to not express myomerger in skeletal muscle, the animals did not develop enough muscle fiber to live.

"These findings stimulate new avenues for cell therapy approaches for regenerative medicine," said Douglas Millay, PhD, study senior investigator and a scientist in the Division of Molecular Cardiovascular Biology at Cincinnati Children's. "This includes the potential for cells expressing myomaker and myomerger to be loaded with therapeutic material and then fused to diseased tissue. An example would be muscular dystrophy, which is a devastating genetic muscle disease. The fusion technology possibly could be harnessed to provide muscle cells with a normal copy of the missing gene."

Bio-Pioneering in Reverse

One of the molecular mysteries hindering development of regenerative therapy for muscles is uncovering the precise genetic and molecular processes that cause skeletal muscle stem cells (called myoblasts) to fuse and form the striated muscle fibers that allow movement. Millay and his colleagues are identifying, deconstructing and analyzing these processes to search for new therapeutic clues.

Genetic degenerative disorders of the muscle number in the dozens, but are rare in the overall population, according to the National Institutes of Health. The major categories of these devastating wasting diseases include: muscular dystrophy, congenital myopathy and metabolic myopathy. Muscular dystrophies are a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. The most common form is Duchenne MD.

Molecular Sleuthing

A previous study authored by Millay in 2014 identified myomaker and its gene through bioinformatic analysis. Myomaker is also required for myoblast stem cells to fuse. However, it was clear from that work that myomaker did not work alone and needed a partner to drive the fusion process. The current study indicates that myomerger is the missing link for fusion, and that both genes are absolutely required for fusion to occur, according to the researchers.

To find additional genes that regulate fusion, Millay's team screened for those activated by expression of a protein called MyoD, which is the primary initiator of the all the genes that make muscle. The team focused on the top 100 genes induced by MyoD (including GM7325/myomerger) and designed a screen to test the factors that could function within and across cell membranes. They also looked for genes not previously studied for having a role in fusing muscle stem cells. These analyses eventually pointed to a previously uncharacterized gene listed in the database - Gm7325.

Researchers then tested cell cultures and mouse models by using a gene editing process called CRISPR-Cas9 to demonstrate how the presence or absence of myomaker and myomerger - both individually and in unison - affect cell fusion and muscle formation. These tests indicate that myomerger-deficient muscle cells called myocytes differentiate and form the contractile unit of muscle (sarcomeres), but they do not join together to form fully functioning muscle tissue.

Looking Ahead

The researchers are building on their current findings, which they say establishes a system for reconstituting cell fusion in mammalian cells, a feat not yet achieved by biomedical science.

For example, beyond the cell fusion effects of myomaker and myomerger, it isn't known how myomaker or myomerger induce cell membrane fusion. Knowing these details would be crucial to developing potential therapeutic strategies in the future, according to Millay. This study identifies myomerger as a fundmentally required protein for muscle development using cell culture and laboratory mouse models.

The authors emphasize that extensive additional research will be required to determine if these results can be translated to a clinical setting.

Explore further: Researchers turn stem cells into somites, precursors to skeletal muscle, cartilage and bone

More information: Nature Communications (2017). DOI: 10.1038/NCOMMS15665

Adding just the right mixture of signaling moleculesproteins involved in developmentto human stem cells can coax them to resemble somites, which are groups of cells that give rise to skeletal muscles, bones, and cartilage ...

A team led by Jean-Franois Ct, researcher at the IRCM, identified a ''conductor'' in the development of muscle tissue. The discovery, published online yesterday by the scientific journal Proceedings of the National ...

Athletes, the elderly and those with degenerative muscle disease would all benefit from accelerated muscle repair. When skeletal muscles, those connected to the bone, are injured, muscle stem cells wake up from a dormant ...

Johns Hopkins researchers report they have inadvertently found a way to make human muscle cells bearing genetic mutations from people with Duchenne muscular dystrophy (DMD).

Duchenne muscular dystrophy is a chronic disease causing severe muscle degeneration that is ultimately fatal. As the disease progresses, muscle precursor cells lose the ability to create new musclar tissue, leading to faster ...

Researchers at Sanford Burnham Prebys Medical Research Institute (SBP) have conclusively identified the protein complex that controls the genes needed to repair skeletal muscle. The discovery clears up deep-rooted conflicting ...

A University of California, Berkeley, study of mice reveals, for the first time, how puberty hormones might impede some aspects of flexible youthful learning.

The human body runs according to a roughly 24-hour cycle, controlled by a "master" clock in the brain and peripheral clocks in other parts of the body that are synchronized according to external cues, including light. Now, ...

The bacteria in a child's gut appears to be influenced as early as its first year by ethnicity and breastfeeding, according to a new study from McMaster University.

Cholesterol, a naturally occurring compound at the lung surface, has been shown to have a clear effect on the properties of this nanoscale film that covers the inside of our lungs. Cholesterol levels in this system may affect ...

A detour on the road to regenerative medicine for people with muscular disorders is figuring out how to coax muscle stem cells to fuse together and form functioning skeletal muscle tissues. A study published June 1 by Nature ...

Researchers from Monash University have developed a new drug delivery strategy able to block pain within the nerve cells, in what could be a major development of an immediate and long lasting treatment for pain.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read the rest here:
One gene closer to regenerative therapy for muscular disorders - Medical Xpress

Posted in Cell Medicine | Comments Off on One gene closer to regenerative therapy for muscular disorders – Medical Xpress

Stem Cell Therapy – Checkbiotech.org (press release)

Posted: June 2, 2017 at 6:41 am

Stem Cell Therapy is poised to change the face of medicine.

Thousands of published studies and or testimonialscan be wrong! Regeneration or Regenerative Medicine has the ability to change almost all facets of medicine.

Doctors are using them on themselves to help with problems and or provide with a better quality of life, in-fact one doctor sais in a recent stem cell seminar that he would be doing them every year just for preventative maintenance.

Stem Cells have been studied for decades however in the past few years a real breakthrough in using Human UmbilicalCell Tissue (HUCT) being harvested from healthy mommy / healthy baby umbilical cords.

Studies have proved that the older you get the fewer stem cells in the body, ruling out the effectiveness of stem cells extracted from your aging body or your fat.

Statin drugs have been proven to diminishstem cells

Using Concentrated Umbilical-Cord Potentcy Stem Cells (CUP STEM CELLS) give you cell counts in the millions ffrom a newborn tht may allow stem cells to duplicate every 28 hours, over 65 or so cucles making CUP STEM CELLS very favorable to all the other options available in the past.

Continued here:
Stem Cell Therapy - Checkbiotech.org (press release)

Posted in Cell Therapy | Comments Off on Stem Cell Therapy – Checkbiotech.org (press release)

Lonza buys Dutch cell and gene therapy CMO – FiercePharma

Posted: June 2, 2017 at 6:41 am

Even as CDMO Lonza deals with FDA concerns about its cell manufacturing operationin the U.S., it has gone out and acquired a gene and cell contract manufacturer in Europe.

Lonza last week said it had acquired Netherlands-based PharmaCell for an undisclosed sum. It said the company had revenues of about 11 million last year. The company has a 15,500 cell manufacturing facility in Maastricht, The Netherlands, which can produce clinical through commercial-scale product.

Lonza said PharmaCell was primarily selected because of its expertise in autologous cell and gene therapy manufacturing, which includes experience with two licensedproducts in Europe.

"PharmaCells position in the market complements Lonzas leadership position in the allogeneic cell manufacturing market," Andreas Weiler, head of emerging technologies at Lonza said in a statement.

Autologous therapies use a patients own cells to create custom products as opposed to allogeneic therapies which can be manufactured in large batches from unrelated donor tissues such as bone marrow which can be used in off-the-shelf therapies. .

Loza said with this deal its gene therapy manufacturing network will span Europe, Asia and the U.S. It is Lonzas U.S. operation in the U.S. that recently ran into FDA concerns. Lonza had its cell therapy facility in Walkersville, Maryland,slapped with a warning letter in April after earlier halting some production of liquid media products being produced for a client.

The plant is overseen by the FDAs devices unit because its products are used for diagnostics. The letter said that retained samples were found to have Pantoea organisms that Lonza discovered after receiving two confirmed complaints for sterility failures of a of product.

A spokesperson said when the warning letter was issued that the company expects to have the problems resolved and FFM media manufacturing back online by mid-2017. The company had already begun a $7.6 million manufacturing upgrade at the facility, which is slated to be finished in 2018.

Excerpt from:
Lonza buys Dutch cell and gene therapy CMO - FiercePharma

Posted in Cell Therapy | Comments Off on Lonza buys Dutch cell and gene therapy CMO – FiercePharma

How Diabetes Is Transforming People Into Real-Life Cyborgs – Geek

Posted: June 2, 2017 at 6:40 am

Diabetes both type 1, which is an incurable autoimmune disorder, and type 2 which is a lifestyle disease that can be reversed or cured are among the fastest-growing diagnoses in the world. Left untreated, they can cause life-threatening conditions and death. So its not surprising that the medical establishment is pumping resources into new methods of management.

What makes them worthy of talking about here on Geek is that technology is playing a major role. Todays diabetic is often wired up with Bluetooth sensors and custom software that turn them into virtual cyborgs with an awareness of their body chemistry that normal people cant match.

Heres a quick rundown of diabetes if youre not familiar with the condition. When you eat food, its split into three basic categories: carbohydrates, fats, and proteins. Carbohydrates, which are found primarily in plant products, break down into a sugar called glucose in your digestive system. That glucose is turned into fuel to power your mind and muscles.

The body does that conversion with a hormone called insulin, which is produced by beta cells in the pancreas. Type 1 diabetics dont make it at all their immune system destroys those beta cells for an as yet unknown reason. Type 2 diabetics make it, but for some reason its less efficient at breaking down glucose into energy.

When the body cant break down glucose, it has to get energy from other places mostly fat, but nothing is safe. That leads to a state of ketosis, where acids released from fats build up. Those acids can cause a wide variety of nerve and tissue damage.

So the life of a diabetic is basically monitoring their carbohydrate intake and then injecting an appropriate amount of insulin, based on a series of complex mathematical formulas, to match it. Too little and they go into ketosis. Too much insulin can drop their blood sugar dangerously low, which can lead to comas and death. Its a delicate tightrope that they walk every day.

The last few decades have seen advances in diabetes treatment that will blow your mind. To put them into context, lets rewind 50 years or so to look at what treatment was like.

Back in the day, a diabetic would wake up every morning and pee into a test tube. Theyd then drop a tablet into it that would change color to tell them what range their blood sugar was in high, normal or low. Theyd then take a single injection of long-lasting time-release insulin that would do for the entire day and hope for the best. When they were done, theyd take the syringe, boil it on the stove to sterilize it and put it back for tomorrow.

Needless to say, the life expectancy for diabetics was pretty short. Without a way to detect highs or lows, their bodies were at the mercy of a variety of factors and many died.

So there were two problems facing diabetics: being able to monitor blood sugar and being able to deliver the appropriate amount of insulin, no more, no less.

Monitoring got easier with the invention of the fingerprick blood glucose monitor in 1981. A drop of blood is introduced to an enzyme, and then an electrical current is passed through it. The number of electrons the sample loses correlates to the amount of glucose present in the sample. This allowed for significantly more precision, delivering a numerical representation of the patients current blood sugar.

That was coupled with the development of faster-acting insulin, so diabetics could treat highs as they happened. The next wave of diabetes care required them to be a more active participant in their management, checking glucose throughout the day and making adjustments as needed. As cool as this was, technology was about to get involved in a big way.

Fingerprick glucose is accurate but requires the diabetic to go through a process every time they want to check (and only works when theyre awake). The threat of low blood sugars at night is a very real one, as glucose levels can drop quickly. An accidental scientific discovery in the mid-1990s helped change the lives of diabetics around the world.

Researchers were experimenting with the bodys cell fluid in the skin and discovered that it basically mirrors the blood glucose level with about a 15-minute delay. In 1999, MiniMed got FDA approval for the first continuous glucose monitor an electrode thats inserted into a diabetics skin that transmits a reading every five minutes without the need to draw blood. Now patients could get real-time feedback on their blood sugar throughout the day. Those early sensors were good for about three days before the bodys immune system rejected them, but modern ones can go for a week or more before theyre changed.

Monitoring that accurate is all well and good, but a diabetic would still need to give themselves an injection to bring high blood sugar down. However, an earlier invention made that process significantly easier. In 1973, Dean Kamen (inventor of the Segway) debuted the worlds first wearable insulin pump, a device that could dose any amount of insulin to a diabetic through a cannula, or small tube, that attached to the body. This gave diabetics even more control over their treatment, enabling them to microdose and control exactly how much of the hormone they receive.

Pumps have advanced significantly over the last decade, with one the Omnipod not needing a tube at all, but affixing directly to the skin and communicating wirelessly with a control device. Patients who manage diabetes with these devices are uniformly in better condition, and even though only one in a thousand diabetics currently uses a pump, that number is rising.

The next step is the artificial pancreas, a device that combines the two into one. These have passed clinical trials and are being rolled out slowly by endocrinologists around the country. Using complex algorithms, they monitor blood glucose and treat it at the same time in a closed-loop system, also administering glucose when blood sugars are too low. Early results are incredibly positive. Like existing pumps and CGMs, they still have to be changed out regularly, but the system marks a significant advance in treatment.

The future of diabetes is even more exciting. Companies are working on insulin that doesnt have to be injected, but rather is absorbed through the skin with a sound-activated patch. Another brand can be inhaled before a meal. Google is collaborating with contact lens manufacturer Alcon on a lens that measures blood sugar through the eye.

So if you see somebody walking around with some little gray boxes attached to their arms or stomach, its highly possible that theyre toting around a cyborg pancreas, wired into the cloud and keeping them healthy.

See the original post here:
How Diabetes Is Transforming People Into Real-Life Cyborgs - Geek

Posted in Diabetes | Comments Off on How Diabetes Is Transforming People Into Real-Life Cyborgs – Geek

Versailles teen continues mission to strike out diabetes – WKYT

Posted: June 2, 2017 at 6:40 am

VERSAILLES, Ky.(WKYT) Saturday June 3, 2017 hundreds will come together to walk and run in an effort to help stop diabetes.

In Kentucky more than 300,000 people of all ages are living with diabetes.

One of those taking part this weekend is Parker Thomas, a young man from Woodford County who has used his diagnosis to help in the fight to find a cure from a very young age. As WKYT's Amber Philpott reports Thomas hopes his work will inspire others battling the disease to get involved.

WKYT first introduced you to Parker Thomas back in 2011, the spunky then 12-year-old was all about baseball and wasn't shy when asked about something very personal.

"On a daily basis I check around 10 to 12 times a day probably," said Parker Thomas.

The little leaguer, diagnosed at the age of eight looked at diabetes like a pitcher would face a batter. For Parker, striking it out became his mission.

"I want to find a cure, why not."

To do that, Parker and his family joined the annual Step Out Walk to Stop Diabetes in Lexington, raising money to find that cure.

Parker also became a Youth Ambassador for the American Diabetes Association serving as a role model to countless youngsters with diabetes.

Fast forward to 2017, Parker now 18 just finished up his senior year at Woodford County High School. To this day, that mission and diabetes are still an everyday part of his life.

"It's never ending obviously, but I feel like we've definitely made strides from going from an insulin pen to a pump which has been miraculous. Right now it's the closest thing to a cure we have."

On Saturday Parker and his Scoops Crew team will again take part in that walk. His team is always easy to spot in the "scoops" shirts that have helped him raise some $30,000.

Parker says this year is the last Scoops Crew shirts he will hand out; he is headed off to college this fall to play baseball.

It's a bittersweet yet proud moment for Parker's mom.

"He used to be inspired by others and now I'm seeing others inspired by him and as a mom what more can you ask for," said Carrie Thomas.

Parker has done his best to strike out diabetes, now he's hoping his work will inspire another youngster to step up to bat to help in the fight to find a cure.

Parker says despite hanging up his fundraising hat, he will be back for the walk in years to come, and he will always support the ADA.

You can support the annual Step Out Walk this Saturday, June 3 at Keeneland. There is a 3 mile walk and run offered. For more information click on the link you see on this page.

Read this article:
Versailles teen continues mission to strike out diabetes - WKYT

Posted in Diabetes | Comments Off on Versailles teen continues mission to strike out diabetes – WKYT

New tech helping Type 1 Diabetes patient race to marathon finish line – 10News

Posted: June 2, 2017 at 6:40 am

LA JOLLA, Calif. (KGTV) - This weekend 30,000 runners will be taking over the streets of San Diego for the Rock 'n' Roll Marathon. They'll be able to tackle either a 5K, half marathon or full marathon.

For Kristy Castillo, it will be her first time running the full course, 26 miles. A few years ago, it was something she never thought was in her reach.

"It was always a roadblock as far as me wanting to get engaged in intense activity."

That's because Castillo lives with Type 1 Diabetes. Her body doesn't produce the insulin needed to process sugar and produce energy. Long distance running or any intense exercise sends her blood sugar levels on a rollercoaster, spiking and dropping.

"When your sugars go up you feel more sluggish, your performance isn't as good. When blood sugars go down, you feel real jittery," said Castillo.

It will be the longest race of her life. But in addition to her training, she'll also be armed with a new device that will not only monitor her blood sugar but pump insulin at the same time.

With Continuous Glucose Monitoring (CGM), patients are able to measure glucose levels in real-time throughout the day and night. It's also waterproof.

"Over those few weeks, it started learning my body and the rhythms and is keeping my blood sugar steady during these intense runs."

Dr. Athena Philis-Tsimikas, Corporate Vice President for the Scripps Whittier Diabetes Institute, says the device is a game-changer for patients.

"It really will allow patients who previously had to think of everything, they had to be the brains behind how to inject their insulin, they now allow that process to be automated," said Philis-Tsimikas.

Leaving patients like Castillo in control of their diabetes.

"It's a part of me, and it can take this journey with me, but I don't want it to define me," said Castillo.

You can follow Castillo's race on Sunday by entering your number here and receiving text messages. Runners will be wearing a GPS chip in their shoes so family and friends can watch their progress ever step of the race.

Read the original here:
New tech helping Type 1 Diabetes patient race to marathon finish line - 10News

Posted in Diabetes | Comments Off on New tech helping Type 1 Diabetes patient race to marathon finish line – 10News

Growing up with diabetes – Las Cruces Sun-News

Posted: June 2, 2017 at 6:40 am

From Wednesday to Friday, the Silva familys life changed. Zahmira Silva, then 7, had a teacher question whether frequent requests to use the restroom could have other explanations than just a desire to get out of class. Zahmira and her parents Rudy and Shawn Silva made an appointment to see the doctor on a Wednesday. The diagnosis: Type 1 diabetes.

I went home to search online and just scared myself, said Shawn.

Overnight our world changed, Rudy said.

By Friday, Zahmira and her parents were in the hospital for a five-day crash course of diabetes education and to get her blood sugar under control.

Diabetes is a disease that affects how the body uses glucose, the main type of sugar in the blood. Typically, bodies naturally break down food into glucose. When the glucose level rises, the pancreas makes the hormone insulin and releases it into the blood. With diabetes, the body doesnt produce insulin (Type 1) or cant respond to insulin properly (Type 2.) In either case, with high blood sugar levels remaining in the body, there can be complications.

Type 1 symptoms include increased thirst and urination, constant hunger, weight loss, and blurred vision. Children also may feel very tired. Type 2 symptoms are progress slowly and include Type 1 symptoms but also frequent infections, slow healing of wounds or sores, yeast infections or burning on urination due to yeast infection. With extreme elevation of glucose in the blood, there may be signs of severe dehydration and coma.

The prevalence of diabetes along the U.S. Mexico border is 16.1 percent compared to 8.3 percent in the U.S. population as a whole. American Diabetes Association

One of the most common disease is school-aged children, diabetes is still a terrifying diagnoses for a parent to hear about their child. In 2012, about 208,000 young people in the U.S. under the age of 20 were diagnosed with diabetes. Many nationwide look to support groups to help navigate this life change.

They taught us how to survive at the hospital, but having a support group, thats where we learned how to live with it and be smart about it, Rudy said.

For five years, the Southern New Mexico Diabetes Outreach has had a support group specifically for children and adolescents who have been diagnosed with Type 1 or Type 2 diabetes. Established in 1998 by local health professionals and other citizens, the organizers were dedicated to helping prevent and manage diabetes affecting the community. Volunteers like Beverly Estrada, the coordinator for the group, create a special connection to the children and parents looking for someone to talk to and learn from Estrada herself was diagnosed at the age of 5 with Type 1 diabetes.

The adjustment for the Silva family, who also have three older sons, was hard, especially at first when they wiped their pantry clean. However, they later learned through education through the support group the wide variety of food they could offer Zahmira.

Its not about deprivation, its about eating properly and how to balance your plate, Estrada said.

Id tell them its not too bad because when you get older it gets easier. Zahmira Silva, diagnosed with Type 1 diabetes at age 7

In the support group, she teaches parents and children about counting carbohydrates such as breads, pasta and rice; and how those can affect blood glucose levels.

Its also dealing with emotions, sometimes self-esteem takes a hit, Estrada explained. No one like changes, because change is never easy and there is nothing worse to be diagnosed with something you may know nothing about.

She notes that diagnosis and journey that follows for the child and family is not an easy one.

Shawna, Zahmira, 10, and Sabian Silva, at a warm up before Zahmira's baseball game on May 15. With Zahmira's Type 1 diabetes diagnosis meant not only a lifestyle change for her, but for her whole family. Support and education is key to maintaining a healthy environment. (Photo: Josh Bachman/Sun-News)

There (are) a million questions, she said. You might feel like youre failing as a parent, and youre guessing, but come out because there are so many in the same shoes walking this journey. Educate yourself, embrace it and take it on and make it your best friend.

Zahmira suggested a simple measure for other kids like her.

Id tell them its not too bad because when you get older it gets easier, she said.

She also thought about how she handled the change in her life, and admitted that she feels pretty normal.

You have two choices: you dont take care of it and the worst happens, or you jump in with both feet, Rudy said. And I feel the proudest of her answer, that she does feel normal.

Cassie McClure is a freelance writer and may be reached at cassiemcclure@gmail.com.

About 208,000 Americans under age 20 have been diagnosed diabetes, approximately 0.25 percent of the population.

From 2008 to 2009, the annual incidence of diagnosed diabetes in youth was estimated at 18,436 with type 1 diabetes, 5,089 with type 2 diabetes.

According to the Centers for Disease Control and Prevention, as of 2012, there are 8.1 million people undiagnosed with diabetes.

25.8 million: The estimated number of children and adults that have diabetes which is 8.3 percent of the population

79 million: The number of Americans with prediabetes

The prevalence of diabetes along the U.S. Mexico border is 16.1 percent compared to 8.3 percent in the U.S. population as a whole.

Hispanics are 1.7 times as likely to have diabetes when compared to non-Hispanic whites.

Source: American Diabetes Association

Southern New Mexico Diabetes Outreach has a support group for elementary-, middle- and high school-age youths from 6 to 7:30 p.m. the first Tuesdays of each month at MountainView Senior Circle Association, 3948 E. Lohman Ave., Suite 1 (behind Walgreens). Snacks are provided. Parents/guardians are required to attend. Children under five are also accepted when diagnosed. Info: 575-522-0289, snmdo.org and snmdo@snmdo.org

El Paso Diabetes Association has two opportunities for children and adolescents with diabetes:

Info: epdiabetes.org, info@epdiabetes.org and 915-532-6280

The American Diabetes Association has a section just for kids with diabetes and their parents, including how to have discussions with your children and strategies for parents together: Info:www.diabetes.org/living-with-diabetes/parents-and-kids

Children with Diabetes highlights the stories of other children with diabetes and tips for parents Info:www.childrenwithdiabetes.com

Myth: People with diabetes should eat special diabetic foods.

Fact: A healthy meal plan for people with diabetes is generally the same as a healthy eating for anyone low in saturated and trans fat, moderate in salt and sugar, with meals based on lean protein, non-starchy vegetables, whole grains, healthy fats and fruit. "Diabetic" foods generally offer no special benefit. Most of them still raise blood glucose levels, are usually more expensive and can also have a laxative effect if they contain sugar alcohols.

Myth: Eating too much sugar causes diabetes.

Fact: The answer is not so simple. Type 1 diabetes is caused by genetics and unknown factors that trigger the onset of the disease; Type 2 diabetes is caused by genetics and lifestyle factors.

Being overweight does increase your risk for developing Type 2 diabetes, and a diet high in calories from any source contributes to weight gain. Research has shown that drinking sugary drinks is linked to Type 2 diabetes.

Myth: People with diabetes can't eat sweets or chocolate.

Fact: If eaten as part of a healthy meal plan, or combined with exercise, sweets and desserts can be eaten by people with diabetes. They are no more "off limits" to people with diabetes than they are to people without diabetes. The key to sweets is to have a very small portion and save them for special occasions so you focus your meal on more healthful foods.

Source: American Diabetes Association

Excerpt from:
Growing up with diabetes - Las Cruces Sun-News

Posted in Diabetes | Comments Off on Growing up with diabetes – Las Cruces Sun-News

Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature – satPRnews (press release)

Posted: May 31, 2017 at 8:46 pm

At StemGenex, we are committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells, said Alexander. Specifically, we use adipose-derived adult stem cell therapy for patients battling conditions such as Multiple Sclerosis, Parkinsons disease, COPD, Rheumatoid Arthritis and Osteoarthritis. We are also committed to the science of stem cell therapy and sponsor five clinical outcome studiesregistered with theNational Institute of Health (NIH) for these diseases.

What I personally witnessed before the start of StemGenex were patients who had exhausted conventional medical treatments but wanted to try alternative therapies. I was one of them, suffering from severe Rheumatoid Arthritis. Ihad only three options; I could seek a clinical trial, travel to outside of the U.S. to try alternative therapies such as stem cell treatment or petition the FDA for access to drugs under the agencys expanded access, or compassionate use program. Now, new state laws, built on model legislation from the Goldwater Institute in Arizona, will potentially allow doctors and patients to make their own informed decisions on treatments that have cleared the safety phase of FDA testing.

Last year, in a move that was seen by some as a response to Right to Try laws, the 21st Century Cures Act, a landmark piece of legislation focused on medical innovation and medical research, was signed into law by President Obama. This Act provides the FDA with the flexibility to accelerate how it evaluates regenerative medicine treatments, such as stem cell therapies, while maintaining its high standards of safety and efficacy.

Were on the cusp of a major change on how patients can access stem cell therapy, saidAlexander. Today, new treatments and advances in research are giving new hope to people affected by a wide range of autoimmune and degenerative illnesses, she said. StemGenex Medical Group is proud to offer the highest quality of care and to potentially help those with unmet clinical needs improve their quality of life.

ABOUT StemGenex Medical Group StemGenex Medical Group is committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells. StemGenex provides stem cell therapy options for individuals suffering with inflammatory and degenerative illnesses. Committed to the science and innovation of stem cell treatment,StemGenex sponsors five clinical outcome studiesregistered with theNational Institutes of Health (NIH) for Multiple Sclerosis, Parkinsons Disease, Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease (COPD) and Osteoarthritis. These have been established to formally document and evaluate the quality of life changes in individuals following adipose-derived stem cell treatment.

Contact: Jamie Schubert, Director of Media & Community Relations jschubert@StemGenex.com, (858) 242-4243

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/patient-centered-stem-cell-therapy-bill-passed-by-texas-legislature-300465987.html

SOURCE StemGenex Medical Group

https://stemgenex.com/

See the rest here:
Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature - satPRnews (press release)

Posted in Arizona Stem Cells | Comments Off on Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature – satPRnews (press release)

Page 1,574«..1020..1,5731,5741,5751,576..1,5801,590..»